Pseudomonas aeruginosa Modulates the Antiviral Response of Bronchial Epithelial Cells

被引:16
作者
Soerensen, Michael [1 ,2 ]
Kantorek, Julia [1 ]
Byrnes, Lauren [1 ]
Boutin, Sebastien [1 ,3 ]
Mall, Marcus A. [4 ,5 ]
Lasitschka, Felix [6 ,7 ]
Zabeck, Heike [8 ]
Dao Nguyen [9 ,10 ]
Dalpke, Alexander H. [1 ,3 ,11 ]
机构
[1] Univ Hosp Heidelberg, Dept Infect Dis Med Microbiol & Hyg, Heidelberg, Germany
[2] Lab Enders & Partners, Stuttgart, Germany
[3] Univ Hosp Heidelberg, Translat Lung Res Ctr Heidelberg TLRC, German Ctr Lung Res DZL, Heidelberg, Germany
[4] Charite Univ Med Berlin, Dept Pediat Pulmonol Immunol & Intens Care Med, Berlin, Germany
[5] BIH, Berlin, Germany
[6] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany
[7] German Ctr Infect Res DZIF, TI Biobanking, Heidelberg, Germany
[8] Univ Hosp Heidelberg, Thoraxklin, Heidelberg, Germany
[9] McGill Univ, Hlth Ctr, Res Inst, Meakins Christie Labs, Montreal, PQ, Canada
[10] McGill Univ, Dept Med, Montreal, PQ, Canada
[11] Tech Univ Dresden, Inst Med Microbiol & Hyg, Med Fac, Dresden, Germany
来源
FRONTIERS IN IMMUNOLOGY | 2020年 / 11卷
关键词
Pseudomonas aeruginosa; cystic fibrosis; virus; antiviral response; interferon; protease; LasR; CYSTIC-FIBROSIS AIRWAY; INTERFERON INDUCTION; RESPIRATORY VIRUSES; SERUM ANTIBODIES; INFECTION; EXACERBATIONS; CHILDREN; MICROBIOTA; ADAPTATION; THERAPY;
D O I
10.3389/fimmu.2020.00096
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cystic fibrosis (CF) patients frequently acquire Pseudomonas aeruginosa infections that have been associated with a bad prognosis and an increased rate of pulmonary exacerbations. Respiratory viruses can cause exacerbations in chronic pulmonary diseases including COPD or asthma and have been suggested to contribute to exacerbations also in CF. In this study we investigated a possible link between P. aeruginosa infection and susceptibility to respiratory viruses. We show that P. aeruginosa is able to block the antiviral response of airway epithelial cells thereby promoting virus infection and spread. Mechanistically, P. aeruginosa secretes the protease AprA in a LasR dependent manner, which is able of directly degrading epithelial-derived IFN lambda resulting in inhibition of IFN signaling. In addition, we correlate the virus infection status of CF patients with the ability of patients' P. aeruginosa isolates to degrade IFN lambda. In line with this, the infection status of CF patients correlated significantly with the amount of respiratory viruses in sputum. Our data suggest that the interplay between P. aeruginosa and respiratory virus infections might partially explain the association of increased rates of pulmonary exacerbations and P. aeruginosa infections in CF patients.
引用
收藏
页数:14
相关论文
共 68 条
  • [1] Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract
    Andreakos, Evangelos
    Salagianni, Maria
    Galani, Ioanna E.
    Koltsida, Ourania
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [2] Inhibition of Pseudomonas aeruginosa Virulence: Characterization of the AprA-AprI Interface and Species Selectivity
    Bardoel, Bart W.
    van Kessel, Kok P. M.
    van Strijp, Jos A. G.
    Milder, Fin J.
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2012, 415 (03) : 573 - 583
  • [3] Pseudomonas aeruginosa Cif Protein Enhances the Ubiquitination and Proteasomal Degradation of the Transporter Associated with Antigen Processing (TAP) and Reduces Major Histocompatibility Complex (MHC) Class I Antigen Presentation
    Bomberger, Jennifer M.
    Ely, Kenneth H.
    Bangia, Naveen
    Ye, Siying
    Green, Kathy A.
    Green, William R.
    Enelow, Richard I.
    Stanton, Bruce A.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (01) : 152 - 162
  • [4] One time quantitative PCR detection of Pseudomonas aeruginosa to discriminate intermittent from chronic infection in cystic fibrosis
    Boutin, Sebastien
    Weitnauer, Michael
    Hassel, Selina
    Graeber, Simon Y.
    Stahl, Mirjam
    Dittrich, A. Susanne
    Mall, Marcus A.
    Dalpke, Alexander H.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2018, 17 (03) : 348 - 355
  • [5] Pseudomonas aeruginosa protease IV enzyme assays and comparison to other pseudomonas proteases
    Caballero, AR
    Moreau, JM
    Engel, LS
    Marquart, ME
    Hill, JM
    O'Callaghan, RJ
    [J]. ANALYTICAL BIOCHEMISTRY, 2001, 290 (02) : 330 - 337
  • [6] Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC
  • [7] Pseudomonas aeruginosa Suppresses Interferon Response to Rhinovirus Infection in Cystic Fibrosis but Not in Normal Bronchial Epithelial Cells
    Chattoraj, Sangbrita S.
    Ganesan, Shyamala
    Faris, Andrea
    Comstock, Adam
    Lee, Wai-Ming
    Sajjan, Umadevi S.
    [J]. INFECTION AND IMMUNITY, 2011, 79 (10) : 4131 - 4145
  • [8] Bacterial Pathogens Activate a Common Inflammatory Pathway through IFNλ Regulation of PDCD4
    Cohen, Taylor S.
    Prince, Alice S.
    [J]. PLOS PATHOGENS, 2013, 9 (10)
  • [9] Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial intervention
    Cuthbertson, Leah
    Rogers, Geraint B.
    Walker, Alan W.
    Oliver, Anna
    Green, Laura E.
    Daniels, Thomas W. V.
    Carroll, Mary P.
    Parkhill, Julian
    Bruce, Kenneth D.
    van der Gast, Christopher J.
    [J]. ISME JOURNAL, 2016, 10 (05) : 1081 - 1091
  • [10] Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients
    D'Argenio, David A.
    Wu, Manhong
    Hoffman, Lucas R.
    Kulasekara, Hemantha D.
    Deziel, Eric
    Smith, Eric E.
    Nguyen, Hai
    Ernst, Robert K.
    Freeman, Theodore J. Larson
    Spencer, David H.
    Brittnacher, Mitchell
    Hayden, Hillary S.
    Selgrade, Sara
    Klausen, Mikkel
    Goodlett, David R.
    Burns, Jane L.
    Ramsey, Bonnie W.
    Miller, Samuel I.
    [J]. MOLECULAR MICROBIOLOGY, 2007, 64 (02) : 512 - 533